Suchergebnisse - "Tamura, Tomohide"

PubPharm (609)

81

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

enthalten in: Investigational new drugs | 2017

von Tambo, Y. | Hosomi, Y. | Sakai, H. | +15

82

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

enthalten in: Investigational new drugs | 2017

von Tambo, Y. | Hosomi, Y. | Sakai, H. | +15

83

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

enthalten in: Investigational new drugs | 2017

von Tambo, Y. | Hosomi, Y. | Sakai, H. | +15

84

A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors

enthalten in: Japanese journal of clinical oncology | 2017

von Nokihara, H. | Yamamoto, N. | Yamada, Y. | +8

85

Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer

enthalten in: Lung cancer | 2017

von Kato, T. | Masuda, N. | Nakanishi, Y. | +10

86

Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer

enthalten in: Lung cancer | 2017

von Katakami, N. | Hida, T. | Nokihara, H. | +9

87

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

enthalten in: Investigational new drugs | 2016

von Yamamoto, N. | Nokihara, H. | Yamada, Y. | +7

88

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

enthalten in: Investigational new drugs | 2016

von Yamamoto, N. | Nokihara, H. | Yamada, Y. | +7

89

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

enthalten in: Investigational new drugs | 2016

von Yamamoto, N. | Nokihara, H. | Yamada, Y. | +7

90

Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy

enthalten in: Cancer science | 2016

von Hida, T. | Nakagawa, K. | Seto, T. | +11